TrivarX Limited | ABN 58 008 130 336 T +61 8 6189 1155 | A: C/- Bio101 Financial Advisory Pty Ltd, Suite 1.01 117 Camberwell Road, Hawthorn East VIC 3123 Corporate Governance Statement The Board of Directors of TrivarX Limited (TrivarX or the Company) ABN 58 008 130 336 is...
Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from TrivarX
- 2026 Annual Report
- Stabl-Im Clinical Development Update
- Notice of AGM and Closing Date for Director Nominations
- Appendix 4E - Preliminary Final Report
- June 2026 Quarterly Activities Report and Appendix 4C
Later from TrivarX
- Appendix 4G
- Notification of cessation of securities - TRI
- Change of Director's Interest Notice - Chris Ntoumenopoulos
- Change of Director's Interest Notice - David Trimboli
- Syntro Health Appointed to Support Stabl-Im Clinical Program
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX